Support chronic pain thanks to the endocannabinoid agent PEA
Recently, significant progress has revolutionized knowledge of the pharmacology of cannabinoid derivatives. Synthetic cannabinoids such as PEA have been developed and an endocannabinoid system has been identified as well as the receptors and ligands that constitute it. Current clinical data strongly support the analgesic properties of cannabinoids on inflammatory and neuropathic pain. Focus on PEA … Read more